Amedisys, Inc. (AMED)

Amedisys Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-9.75	118.61	209.07	183.61	126.83
Depreciation & Amortization	57.84	70.96	71.27	67.94	54.33
Share-Based Compensation	29.02	16.56	23.81	26.73	25.04
Other Operating Activities	60.07	-72.85	-115.25	10.67	-4.21
Operating Cash Flow	137.19	133.28	188.89	288.95	202
Operating Cash Flow Growth	2.93%	-29.44%	-34.63%	43.05%	-9.61%
Capital Expenditures	-5.48	-6.1	-6.16	-5.25	-7.73
Acquisitions	47.44	-71.95	-269.97	-298.96	-345.46
Change in Investments	0.15	-15.64	-5.2	17	-0.21
Other Investing Activities	-7.04	-0.8	-0.28	0.1	0.45
Investing Cash Flow	35.06	-94.49	-281.61	-287.11	-352.95
Share Issuance / Repurchase	2.7	-11.2	-93.86	9.89	6.8
Debt Issued / Paid	-76.01	-13.3	227.38	-29.25	231.03
Other Financing Activities	-14.21	-5.94	-78.4	4.39	-10.62
Financing Cash Flow	-87.52	-30.43	55.13	-14.98	227.21
Net Cash Flow	84.73	8.36	-37.59	-13.13	76.26
Free Cash Flow	131.7	127.18	182.74	283.7	194.27
Free Cash Flow Growth	3.55%	-30.40%	-35.59%	46.03%	-10.46%
Free Cash Flow Margin	5.89%	5.72%	8.25%	13.70%	9.93%
Free Cash Flow Per Share	4.04	3.91	5.60	8.71	6.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).